Search
Neogenomics Inc
NEOAdd to Watchlist
14.970USD
+0.380+2.60%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.95BMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-01 The current financial score of Neogenomics Inc is 7.13, ranking 51 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 186.67M, representing a year-over-year increase of 11.09%, while its net profit experienced a year-over-year increase of 34.01%.
Financials
7.40
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.09
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
8.21
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
5.78
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.18
Free cash flow
Relevant data have not been disclosed by the company yet.